CHRISTINA CATALFANO: Open Payments
NPI 1093062358 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 13 payments from 9 companies in 2025. Trend: 2023 $477 · 2024 $752 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 3 | $51 |
| Gilead Sciences, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| ABBVIE INC. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: ACCRUFER, TRELEGY ELLIPTA, Kerendia, OTEZLA, Ozempic, MAVYRET, VOQUEZNA, UBRELVY.
Industry payments across NY — which companies pay providers there.
